These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 7586057)
1. Synthesis and structure-activity relationships of 4-amino-5-chloro-2-ethoxybenzamides with six- and seven-membered heteroalicycles as potential gastroprokinetic agents. Morie T; Kato S; Harada H; Yoshida N; Fujiwara I; Matsumoto J Chem Pharm Bull (Tokyo); 1995 Jul; 43(7):1137-47. PubMed ID: 7586057 [TBL] [Abstract][Full Text] [Related]
2. Novel benzamides as selective and potent gastrokinetic agents. 2. Synthesis and structure-activity relationships of 4-amino-5-chloro-2-ethoxy-N-[[4-(4-fluorobenzyl)-2- morpholinyl]methyl] benzamide citrate (AS-4370) and related compounds. Kato S; Morie T; Kon T; Yoshida N; Karasawa T; Matsumoto J J Med Chem; 1991 Feb; 34(2):616-24. PubMed ID: 1995885 [TBL] [Abstract][Full Text] [Related]
3. Novel benzamides as selective and potent gastric prokinetic agents. 1. Synthesis and structure-activity relationships of N-[(2-morpholinyl)alkyl]benzamides. Kato S; Morie T; Hino K; Kon T; Naruto S; Yoshida N; Karasawa T; Matsumoto J J Med Chem; 1990 May; 33(5):1406-13. PubMed ID: 2139471 [TBL] [Abstract][Full Text] [Related]
4. Novel benzamides as selective and potent gastrokinetic agents. IV. Synthesis and structure-activity relationships of 2-substituted 4-amino-N-[(4-benzyl-2-morpholinyl)methyl]-5-chlorobenzamides. Kato S; Morie T; Yoshida N; Matsumoto J Chem Pharm Bull (Tokyo); 1992 Jun; 40(6):1470-5. PubMed ID: 1394664 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological activities of the optical isomers of (+/-)-4-amino-5-chloro-2-ethoxy-N-[[4-(4-fluorobenzyl)-2- morpholinyl]methyl]benzamide (mosapride). Morie T; Kato S; Harada H; Yoshida N; Matsumoto J Chem Pharm Bull (Tokyo); 1994 Apr; 42(4):877-82. PubMed ID: 8020122 [TBL] [Abstract][Full Text] [Related]
6. Novel benzamides as selective and potent gastrokinetic agents. III. Synthesis and structure-activity relationships of 4-amino-5-chloro-2-methoxy- and 2-ethoxy-N-[(4-substituted 2-morpholinyl)methyl]-benzamides. Kato S; Morie T; Harada H; Yoshida N; Matsumoto J Chem Pharm Bull (Tokyo); 1992 Mar; 40(3):652-60. PubMed ID: 1535291 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological activity of 4-amino-5-chloro-2-ethoxy-3-hydroxybenzamides, metabolites of a new gastroprokinetic agent, mosapride. Kato S; Morie T; Yoshida N Chem Pharm Bull (Tokyo); 1996 Aug; 44(8):1484-92. PubMed ID: 8795267 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological activities of metabolites of mosapride, a new gastroprokinetic agent. Kato S; Morie T; Yoshida N Chem Pharm Bull (Tokyo); 1995 Apr; 43(4):699-702. PubMed ID: 7600620 [TBL] [Abstract][Full Text] [Related]
9. Development of potent serotonin-3 (5-HT3) receptor antagonists. I. Structure-activity relationships of 2-alkoxy-4-amino-5-chlorobenzamide derivatives. Harada H; Morie T; Hirokawa Y; Yoshida N; Kato S Chem Pharm Bull (Tokyo); 1995 Aug; 43(8):1364-78. PubMed ID: 7553982 [TBL] [Abstract][Full Text] [Related]
10. Nitrogen-containing heteroalicycles with serotonin receptor binding affinity: development of gastroprokinetic and antiemetic agents. Kato S; Fujiwara I; Yoshida N Med Res Rev; 1999 Jan; 19(1):25-73. PubMed ID: 9918193 [TBL] [Abstract][Full Text] [Related]
11. Pharmacological effects of the new gastroprokinetic agent mosapride citrate and its metabolites in experimental animals. Yoshida N; Omoya H; Kato S; Ito T Arzneimittelforschung; 1993 Oct; 43(10):1078-83. PubMed ID: 8267674 [TBL] [Abstract][Full Text] [Related]
12. Novel N-[1-(1-substituted 4-piperidinylmethyl)-4-piperidinyl]benzamides as potent colonic prokinetic agents. Harada H; Yamazaki H; Toyotomi Y; Tateishi H; Mine Y; Yoshida N; Kato S Bioorg Med Chem Lett; 2002 Mar; 12(6):967-70. PubMed ID: 11959005 [TBL] [Abstract][Full Text] [Related]
13. Novel 5-hydroxytryptamine 4 (5-HT4) receptor agonists. Synthesis and gastroprokinetic activity of 4-amino-N-[2-(1-aminocycloalkan-1-yl)ethyl]-5-chloro-2-methoxybenzamide s. Suzuki T; Imanishi N; Itahana H; Watanuki S; Miyata K; Ohta M; Nakahara H; Yamagiwa Y; Mase T Chem Pharm Bull (Tokyo); 1998 Jul; 46(7):1116-24. PubMed ID: 9692218 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and neuroleptic activity of benzamides. Cis-N-(1-benzyl-2-methylpyrrolidin-3-yl)-5-chloro-2-methoxy-4-(methylamino)benzamide and related compounds. Iwanami S; Takashima M; Hirata Y; Hasegawa O; Usuda S J Med Chem; 1981 Oct; 24(10):1224-30. PubMed ID: 6120234 [TBL] [Abstract][Full Text] [Related]
15. Pharmacological studies on new gastrokinetic drugs. Coppi G; Pinzetta A; Barchielli M Acta Physiol Hung; 1990; 75 Suppl():65-6. PubMed ID: 2371904 [No Abstract] [Full Text] [Related]
16. Synthesis, gastrointestinal prokinetic activity and structure-activity relationships of novel N-[[2-(dialkylamino)ethoxy]benzyl]benzamide derivatives. Sakaguchi J; Nishino H; Ogawa N; Iwanaga Y; Yasuda S; Kato H; Ito Y Chem Pharm Bull (Tokyo); 1992 Jan; 40(1):202-11. PubMed ID: 1576675 [TBL] [Abstract][Full Text] [Related]
17. Enhancing effect of DQ-2511 on gastric emptying of spontaneously hypertensive rats. Hatanaka S; Kawarabayashi K; Iseri M; Tsubokura K; Furuhama K Life Sci; 1995; 56(19):PL377-82. PubMed ID: 7723581 [TBL] [Abstract][Full Text] [Related]
18. A novel series of 6-methoxy-1H-benzotriazole-5-carboxamide derivatives with dual antiemetic and gastroprokinetic activities. Hirokawa Y; Yamazaki H; Yoshida N; Kato S Bioorg Med Chem Lett; 1998 Aug; 8(15):1973-8. PubMed ID: 9873469 [TBL] [Abstract][Full Text] [Related]
19. Probes for narcotic receptor-mediated phenomena. 25. Synthesis and evaluation of N-alkyl-substituted (alpha-piperazinylbenzyl)benzamides as novel, highly selective delta opioid receptor agonists. Katsura Y; Zhang X; Homma K; Rice KC; Calderon SN; Rothman RB; Yamamura HI; Davis P; Flippen-Anderson JL; Xu H; Becketts K; Foltz EJ; Porreca F J Med Chem; 1997 Aug; 40(18):2936-47. PubMed ID: 9288176 [TBL] [Abstract][Full Text] [Related]
20. AS-4370, a novel gastrokinetic agent free of dopamine D2 receptor antagonist properties. Yoshida N; Omoya H; Oka M; Furukawa K; Ito T; Karasawa T Arch Int Pharmacodyn Ther; 1989; 300():51-67. PubMed ID: 2533479 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]